acquired
Stage
About
ScoutBio develops one-time biotherapeutic treatments, including monoclonal antibodies and gene therapies, targeting major chronic health conditions in pets.
Explore ScoutBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.